Patients’ perception of Parkinson’s disease-associated pain following initiation of rotigotine: a multicenter non-interventional study

References

• Broen MP, Braaksma MM, Patijn J, et al. Prevalence of pain in Parkinson’s disease: a systematic review using the modified QUADAS tool. Mov Disord. 2012;27:480–484.
   PubMed Web of Science ®Google Scholar
• Li W, Chen Y, Yin B, et al. Pain in Parkinson’s disease associated with COMT gene polymorphisms. Behav Neurol. 2014;2014:304203.
   PubMed Web of Science ®Google Scholar
• Mao CJ, Chen JP, Zhang XY, et al. Parkinson’s disease patients with pain suffer from more severe non-motor symptoms. Neurol Sci. 2015;36:263–268.
   PubMed Web of Science ®Google Scholar
• Wasner G, Deuschl G. Pains in Parkinson disease–many syndromes under one umbrella. Nat Rev Neurol. 2012;8:284–294.
   PubMed Web of Science ®Google Scholar
• Defazio G, Gigante A, Mancino P, et al. The epidemiology of pain in Parkinson’s disease. J Neural Transm (Vienna). 2013;120:583–586.
   PubMed Web of Science ®Google Scholar
• Ha AD, Jankovic J. Pain in Parkinson’s disease. Mov Disord. 2012;27:485–491.
   PubMed Web of Science ®Google Scholar
• Truini A, Frontoni M, Cruccu G. Parkinson’s disease related pain: a review of recent findings. J Neurol. 2013;260:330–334.
   PubMed Web of Science ®Google Scholar
• Politis M, Wu K, Molloy S, et al. Parkinson’s disease symptoms: the patient’s perspective. Mov Disord. 2010;25:1646–1651.
   PubMed Web of Science ®Google Scholar
• Beiske AG, Loge JH, Rønningen A, et al. Pain in Parkinson’s disease: prevalence and characteristics. Pain. 2009;141:173–177.
   PubMed Web of Science ®Google Scholar
• Lee MA, Walker RW, Hildreth TJ, et al. A survey of pain in idiopathic Parkinson’s disease. J Pain Symptom Manage. 2006;32:462–469.
   PubMed Web of Science ®Google Scholar
• Rana A, Saeed U, Masroor MS, et al. A cross-sectional study investigating clinical predictors and physical experiences of pain in Parkinson’s disease. Funct Neurol. 2013;28:297–304.
   PubMedGoogle Scholar
• Valkovic P, Minar M, Singliarova H, et al. Pain in Parkinson’s disease: a cross-sectional study of its prevalence, types, and relationship to depression and quality of life. PLoS ONE. 2015;10:e0136541.
   PubMed Web of Science ®Google Scholar
• Zambito Marsala S, Tinazzi M, Vitaliani R, et al. Spontaneous pain, pain threshold, and pain tolerance in Parkinson’s disease. J Neurol. 2011;258:627–633.
   PubMed Web of Science ®Google Scholar
• Nègre-Pagès L, Regragui W, Bouhassira D, et al. Chronic pain in Parkinson’s disease: the cross-sectional French DoPaMiP survey. Mov Disord. 2008;23:1361–1369.
   PubMed Web of Science ®Google Scholar
• Goetz CG, Tanner CM, Levy M, et al. Pain in Parkinson’s disease. Mov Disord. 1986;1:45–49.
   PubMedGoogle Scholar
• Brefel-Courbon C, Payoux P, Thalamas C, et al. Effect of levodopa on pain threshold in Parkinson’s disease: a clinical and positron emission tomography study. Mov Disord. 2005;20:1557–1563.
   PubMed Web of Science ®Google Scholar
• Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, et al. Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study. J Neurol Neurosurg Psychiatry. 2007;78:1140–1142.
   PubMed Web of Science ®Google Scholar
• Nebe A, Ebersbach G. Pain intensity on and off levodopa in patients with Parkinson’s disease. Mov Disord. 2009;24:1233–1237.
   PubMed Web of Science ®Google Scholar
• Letvinenko IV, Odinak MM, Mogil’naia VI. [Pain and depression in Parkinson’s disease: new therapeutic possibilities of pramipexole]. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108:36–38.
   PubMedGoogle Scholar
• Scheller D, Ullmer C, Berkels R, et al. The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson’s disease. Naunyn Schmiedebergs Arch Pharmacol. 2009;379:73–86.
   PubMed Web of Science ®Google Scholar
• Elshoff JP, Braun M, Andreas JO, et al. Steady-state plasma concentration profile of transdermal rotigotine: an integrated analysis of three, open-label, randomized, phase I multiple dose studies. Clin Ther. 2012;34:966–978.
   PubMed Web of Science ®Google Scholar
• Jankovic J, Watts RL, Martin W, et al. Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease. Arch Neurol. 2007;64:676–682.
   PubMed Web of Science ®Google Scholar
• Watts RL, Jankovic J, Waters C, et al. Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease. Neurology. 2007;68:272–276.
   PubMed Web of Science ®Google Scholar
• Giladi N, Boroojerdi B, Korczyn AD, et al. Rotigotine transdermal patch in early Parkinson’s disease: a randomized, double-blind, controlled study versus placebo and ropinirole. Mov Disord. 2007;22:2398–2404.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Kies B, Rudzinska M, et al. Rotigotine effects on early morning motor function and sleep in Parkinson’s disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord. 2011;26:90–99.
   PubMed Web of Science ®Google Scholar
• Kassubek J, Chaudhuri KR, Zesiewicz T, et al. Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hoc analysis of the RECOVER study. BMC Neurol. 2014;14:42.
   PubMed Web of Science ®Google Scholar
• Rascol O, Zesiewicz T, Chaudhuri KR, et al. A randomized controlled exploratory pilot study to evaluate the effect of rotigotine transdermal patch on Parkinson’s disease-associated chronic pain. J Clin Pharmacol. 2016;56:852–861.
   PubMed Web of Science ®Google Scholar
• dgss.org. Deutsche Schmerzgesellschaft. Available from: http://www.dgss.org. cited 2016 Apr 28.
   Google Scholar
• Korb J, Pfingsten M. Implementierte Psychometrie. Der Schmerz. 2003;17:S47.
   Google Scholar
• Nagel B, Gerbershagen HU, Lindena G, et al. Entwicklung und empirische überprüfung des deutschen schmerzfragebogens der DGSS. Der Schmerz. 2002;16:263–270.
   PubMed Web of Science ®Google Scholar
• Rosenow DE, Tronnier VM, Göbel H. Neurogener schmerz: management von diagnostik und therapie. Heidelberg: Springer; 2005.
   Google Scholar
• Jenkinson C, Fitzpatrick R, Peto V, et al. The PDQ-8: development and validation of a short-form Parkinson’s disease questionnaire. Psychol Health. 1997;12:805–814.
   Web of Science ®Google Scholar
• Thomson GH. The factorial analysis of human ability. London: London University Press; 1951.
   Google Scholar
• Cury RG, Galhardoni R, Fonoff ET, et al. Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms. Eur J Pain. 2016;20:151–165.
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K. Neuroanatomy and pathology of sporadic Parkinson’s disease. Adv Anat Embryol Cell Biol. 2009;201:1–119.
   PubMed Web of Science ®Google Scholar
• Büchel C, Geuter S, Sprenger C, et al. Placebo analgesia: a predictive coding perspective. Neuron. 2014;81:1223–1239.
   PubMed Web of Science ®Google Scholar
• Schwarz KA, Buchel C. Cognition and the placebo effect–dissociating subjective perception and actual performance. PLoS One. 2015;10:e0130492.
   PubMed Web of Science ®Google Scholar